Medicine and Dentistry

1. Patient 100%
2. Neoplasm 92%
3. Radiomics 59%
4. Therapeutic Procedure 50%
5. Neoadjuvant Chemotherapy 46%
6. Esophageal Cancer 43%
7. Analysis 42%
8. Esophageal Adenocarcinoma 41%
9. Hazard Ratio 37%
10. Positron Emission Tomography-Computed Tomography 33%
11. Malignant Neoplasm 27%
12. Adenocarcinoma 27%
13. Chemotherapy 27%
14. Lymph Node 25%
15. Stomach Adenocarcinoma 25%
16. Surgical Margin 24%
17. Cancer Staging 23%
18. Fluorodeoxyglucose F 18 23%
19. Recurrent Disease 22%
20. Esophagectomy 21%
21. Experience 21%
22. COVID-19 19%
23. Cancer Therapy 19%
24. Stereotactic Body Radiation Therapy 19%
25. Glucose 19%
26. Chemotherapy Regimens 19%
27. Liver 19%
28. Medical Research 19%
29. PET-MRI 19%
30. Squamous Cell Carcinoma 19%
31. Magnetic Resonance Imaging 19%
32. Anal Canal 19%
33. Adjuvant Therapy 19%
34. Colorectal Carcinoma 19%
35. Adjuvant Chemoradiotherapy 12%
36. Mixed Tumor 11%
37. Proportional Hazards Model 10%
38. Primary Tumor 10%
39. Disease 9%
40. Infection 9%
41. Radiation Therapy 7%
42. Cohort Analysis 7%
43. Phenotype 6%
44. Morbidity 6%
45. Cancer Mortality 6%
46. Quality of Life 6%
47. Treatment Response 6%
48. Solid Malignant Neoplasm 6%
49. Adverse Event 5%
50. Postoperative Complication 5%